[ Main Page ]

¸¦½¤°å»º²ÊÉÂÅï¥Þ¥Ë¥å¥¢¥ë - È´¿è

¼ê½Ñ»þ¹³À¸ºÞ

CTM 1g¡£ÂÛÈ×Êڽиå¤ËçÁÂÓÆ°Ì®¤«¤éçÁÂӷ쥬¥¹¡¢ÀÅÌ®¤«¤éÀ¸²½¤ò¤È¤ë¡£ ÂÛ»ù²¾»à¡¦pHÅù¤Ë¤Ä¤¤¤Æ¤Ï¸å½Ò¡£Í½ËÉŪ¹³¶ÝÌô¤Î»ÈÍѤϡ¢°ì±þ¡¢2010ǯ¤ËACOG¤«¤éÄ벦ÀÚ³«Á°¤ÎͽËÉŪ¹³¶ÝÌôÅêÍ¿¤Î¿ä¾©À¼ÌÀ¤¬½Ð¤Æ¤¤¤Þ¤¹¤·¡¢ ¤½¤ì¤Ê¤ê¸ú²Ì¤Ï¤¢¤ë¤è¤¦¤Ç¤¹¡£¼¹ÅáÁ°¤Ë¤Á¤ã¤ó¤ÈÅêÍ¿¤¬½ª¤ï¤Ã¤Æ¤¤¤ë¤è¤¦¤ËÃí°Õ¤·¤Þ¤·¤ç¤¦¡£ Obstet Gynecol. 2010 Sep;116(3):791-2. Committee opinion no. 465: antimicrobial prophylaxis for cesarean delivery: timing of administration.

»º²Êά¸ì¤Ê¤É

¡²G¡²P¡Ê´û±ýÎò¤Ëɬ¤º½ñ¤¯¡ËG (graviditas)Ç¥¿±¡¢P (parturition)ʬÊÚ¢ª²¿²óÇ¥¿±¤·¤Æ¡¢²¿²óʬÊÚ¤·¤¿¤«
¡¦NSD (normal spontaneous delivery)¡¡¼«Á³Ê¬ÊÚ SA ή»º¡¢KA ÃæÀä
¡¦CL(cervical length)¡¡·Û´ÉĹ
¡¦GS¡Êgestational sac: ÂÛǹ¡ËCRL¡Êcrown-rump length: ƬÅÂĹ¡ËAGE¡Ê¿äÄêÇ¥¿±½µ¿ô¡ËBPD¡Êbiparietal diameter: »ùƬÂç²£·Ð FL¡Êfemur length: ÂçÂܹüĹ¡ËHC(head circumference: ÂÛ»ùƬ³¸¹ü¼þ°ÏĹ) AC¡Êabdominal circumference: Ê¢Éô¼þ°ÏĹ EFBW¡Êestimated fetal body weight: ¿äÄêÂνšËEDC¡ÊEstimated Date of Confinement.: ½Ð»ºÍ½ÄêÆü¡ËLMP(Last Menstrual Period: ºÇ½ª·î·Ð³«»ÏÆü)
¡¦AFI(Amniotic fluid index: AFI) - Phelan et al. ¤¬Ä󾧤·¤¿ÍÓ¿åÎ̤ÎȾÄêÎÌË¡¤Ç¤¢¤ê¡¤ º£Æü¹­¤¯¼Â»Ü¤µ¤ì¤Æ¤¤¤ëÊýË¡¡¥Ç¥¿±»ÒµÜ¤òÊ¢ÊÉÂÎɽÌ̾å¤Ç4 ʬ³ä¤·¡¤Ä¶²»ÇÈ¥×¥í¡¼¥Ö¤òÇ¥ÉØ¤ÎĹ¼´Êý¸þ¤Ç¾²¤ËÂФ·¤Æ¿âľ¤Ë¤¢¤Æ¡¤ ¤½¤ì¤¾¤ì¤ÎÍÓ¿å¹Ð¤ÎºÇÂ翼ÅÙ¤ò¬Äꤷ¡¤¤½¤ÎÁíϤòcm ¤Çɽ¸½¤¹¤ë¡Ë¡¥Phelan et al¡¥¤Î¿ÇÃÇ´ð½à¤Ï¡¤5.0cm °Ê²¼¤òÍÓ¿å²á¾¯¡¤ 5.1¡Á8.0cm ¤ò¶­³¦°è¡¤8.1¡Á18.0cm ¤òÀµ¾ï¡¤18.1cm °Ê¾å¤òÍÓ¿å²á¿¤È¤·¤Æ¤¤¤ë¤¬¡¤ÍÓ¿å²á¿¤Î¿ÇÃÇ´ð½à¤È¤·¤Æ20cm, 24cm, 25cm ¤òºÎÍѤ·¤Æ¤¤¤ëʸ¸¥¤ä¡¤ÍÓ¿å²á¾¯¤Î¿ÇÃÇ´ð½à¤ò7cm ¤È¤¹¤ë¤â¤Î¤â¤ß¤é¤ì¤ë¡¥
¡¦AFP(amniotic fluid pocket) ¡ä8cm ÍÓ¿å²á¿ ¡ã2cm ÍÓ¿å²á¾¯
¡¦induction ʬÊÚͶȯ¡Ê¿ØÄˤ¬¤Þ¤À̵¤¤¤È¤­¡Ë¡¢augmentation ʬÊÚÂ¥¿Ê¡Ê¿ØÄˤ¬¤¢¤ë¤±¤É¼å¤¤¤È¤­¡Ë
¡¦Kopf Ƭ°Ì BEL(Becken Lage)¹üÈװ̡ʡȥ٥å±¥ó¡É¤È¤¤¤¦¡Ë
¡¦PROM (premature rupture of the membrane) Á°´üÇË¿å
¡¦pPROM(preterm premature rupture of the membrane)
¡¦PIH (pregnancy-induced hypertension) Ç¥¿±¹â·ì°µ¾É
¡¦placenta previa ¡Ê¡È¥×¥ì¥Ó¥¢¡É¡ËÁ°ÃÖÂÛÈ×
¡¦D&C¡Êdilatation and curettage¡Ë/ Aus¡Êauskratzung, ¥É¥¤¥Ä¸ì¡Ë¡¡»ÒµÜÆâÍÆ½üµî½Ñ

¿·À¸»ù²¾»à

¡ãpH7.20 BE¡ä12¤È¤µ¤ì¤Æ¤¤¤ë¤¬pH7ÄøÅ٤ޤǤǤÏǾÀ­Ëãáã¤È¤Î´ØÏ¢¤Ï¤Ê¤¤¤«¤â¤·¤ì¤Ê¤¤¡£ (¡Ç91 ACOG¤Î²¾»à¤ÈËãáã¤È¤Î´ØÏ¢¤ÎÍ×·ï: pH7̤Ëþ¡¢5ʬ´Ö°Ê¾åAp0~3¡¢áÛÚ»¡¦ºª¿ç¡¦¶Ú¶ÛÄ¥°Û¾ï)

ÃÁÇòʬ²ò¹ÚÁÇÁ˳²ÌôÅù

Note: ¥Õ¥é¥¸¡¼¥ë¡Ê¥á¥È¥í¥Ë¥À¥¾¡¼¥ë¡Ë ¥ß¥é¥¯¥ê¥Ã¥É¡Ê¥¦¥ê¥Ê¥¹¥¿¥Á¥ó¡¡ÃÁÇòʬ²ò¹ÚÁÇÁ˳²Ìô¡Ë ¥¯¥í¥Þ¥¤çµ¾û¡Ê¥¯¥í¥é¥à¥Õ¥§¥Ë¥³¡¼¥ë¡Ë

FOY¡§¥á¥·¥ë»À¥¬¥Ù¥­¥µ¡¼¥È
Ùɹ³¡§¥È¥ê¥×¥·¥ó/¥×¥é¥¹¥ß¥ó¥È¥í¥ó¥Ó¥ó¥¨¥¹¥Æ¥é¡¼¥¼
¾ïÍÑ200¡Á600mg/Æü ½Å¾É20~39mg/kg/Æü
¥Õ¥µ¥ó¡§¥á¥·¥ë»À¥Ê¥Õ¥¡¥â¥¹¥¿¥Ã¥È
Ùɹ³¡§¥È¥í¥ó¥Ô¥ó/¥«¥ê¥¯¥ì¥¤¥ó/¥×¥é¥¹¥ß¥ó/¥È¥ê¥×¥·¥ó/PLA2
¾ïÍÑ10¡Á60mg/Æü ½Å¾É1.44~4.8mg/kg/Æü
¥ß¥é¥¯¥ê¥Ã¥É¡§¥¦¥ê¥Ê¥¹¥¿¥Á¥ó
Ùɹ³¡§¥È¥ê¥×¥·¥ó/¥­¥â¥È¥ê¥×¥·¥ó/¥¨¥¹¥Æ¥é¡¼¥¼
¾ïÍÑ5Ëü¡Á15Ëüñ°Ì/Æü ½Å¾É10~30Ëüñ°Ì/Æü

Ç¥¿±ÅüÇ¢ÉÂ(GDM) - Ç¥¿±ÅüǢɿÇÃÇ´ð½à 2010ǯ²þÄê

ÄêµÁ¡§Ç¥¿±ÅüÇ¢ÉÂgestational diabetes mellitus (GDM)¡§Ç¥¿±Ãæ¤Ë¤Ï¤¸¤á¤ÆÈ¯¸«¤Þ¤¿¤Ïȯ¾É¤·¤¿ÅüǢɤˤ¤¤¿¤Ã¤Æ¤¤¤Ê¤¤ÅüÂå¼Õ°Û¾ï¤Ç¤¢¤ë¡£ Ç¥¿±»þ¤Ë¿ÇÃǤµ¤ì¤¿ÌÀ¤é¤«¤ÊÅüÇ¢ÉÂ(overt diabetes in pregnancy)¤Ï´Þ¤á¤Ê¤¤¡£
¿ÇÃÇ´ð½à¡§Ç¥¿±Ãæ¤Ëȯ¸«¤µ¤ì¤ëÂÑÅüǽ°Û¾ïhyperglycemic disorders in pregnancy¤Ë¤Ï¡¢

¤Î2¤Ä¤¬¤¢¤ê¼¡¤Î¿ÇÃÇ´ð½à¤Ë¤è¤ê¿ÇÃǤ¹¤ë

1¡ËÇ¥¿±ÅüǢɠ(GDM) 75gOGTT¤Ë¤ª¤¤¤Æ¼¡¤Î´ð½à¤Î1ÅÀ°Ê¾å¤òËþ¤¿¤·¤¿¾ì¹ç¤Ë¿ÇÃǤ¹¤ë¡£
¶õÊ¢»þ·ìÅüÃÍ¡¡¡æ92mg/dl¡¡(5.1mmol/l)
1»þ´ÖÃÍ¡¡¡æ180mg/dl (10.0mmol/l)
2»þ´ÖÃÍ ¡æ153mg/dl ¡Ê8.5mmol/l¡Ë
2¡ËÇ¥¿±»þ¤Ë¿ÇÃǤµ¤ì¤¿ÌÀ¤é¤«¤ÊÅüǢɡ¡overt diabetes in pregnancy
°Ê²¼¤Î¤¤¤º¤ì¤«¤òËþ¤¿¤·¤¿¾ì¹ç¤Ë¿ÇÃǤ¹¤ë¡£
¶õÊ¢»þ·ìÅüÃÍ¡æ126mg/dl
HbA1C ¡æ6.5¡ó¡ÊHbA1C (JDS) ¡æ6.1¡ó¡ËÃð£±
³Î¼Â¤ÊÅüÇ¢ÉÂÌÖËì¾É¤¬Â¸ºß¤¹¤ë¾ì¹ç
¿ï»þ·ìÅüÃÍ¡æ200mg/dl¤¢¤ë¤¤¤Ï75gOGTT¤Ç2»þ´ÖÃÍ¡æ200mg/dl¤Î¾ì¹ç*

*¤¤¤º¤ì¤Î¾ì¹ç¤â¶õÊ¢»þ·ìÅü¤«HbA1C¤Ç³Îǧ
Ã𣱡¥¹ñºÝɸ½à²½¤ò½Å»ë¤¹¤ëΩ¾ì¤«¤é¡¢¿·¤·¤¤HbA1CÃ͡ʡó¡Ë¤Ï¡¢½¾Íè¤ï¤¬¹ñ¤Ç»ÈÍѤ·¤Æ¤¤¤¿Japan Diabetes Society (JDS)ÃͤË0.4% ¤ò²Ã¤¨¤¿National Glycohemoglobin Standardization Program(NGSP)Ãͤò»ÈÍѤ¹¤ë¤â¤Î¤È¤¹¤ë¡£
Ã𣲡¥HbA1C¡ã 6.5%̤Ëþ(HbA1C¡ÊJDS¡Ë¡ã6.1%̤Ëþ¡Ë¤Ç75gOGTT 2»þ´ÖÃÍ¡æ200mg/dl¤Î¾ì¹ç¤Ï¡¢ Ç¥¿±»þ¤Ë¿ÇÃǤµ¤ì¤¿ÌÀ¤é¤«¤ÊÅüǢɤȤÏȽÄꤷÆñ¤¤¤Î¤Ç¡¢High risk GDM¤È¤·¡¢Ç¥¿±Ãæ¤ÏÅüǢɤ˽स¤¿´ÉÍý¤ò¹Ô¤¤¡¢ ½Ð»º¸å¤ÏÅüǢɤ˰ܹԤ¹¤ë²ÄǽÀ­¤¬¹â¤¤¤Î¤Ç¸·½Å¤Ê¥Õ¥©¥í¡¼¥¢¥Ã¥×¤¬É¬ÍפǤ¢¤ë¡£
½Ðŵ: http://www.dm-net.co.jp/jsdp/top/cri.php

ÍÓ¿åÎÌ

10w-30cc 20w-350cc 38w-1000cc Term 500cc Post-term <500cc

ή»º

ή»º abortion
¡ÎÄêµÁ¡Ï¡¡Î®»º¤È¤Ï¡ÖÇ¥¿±22½µÌ¤Ëþ¤ÎÇ¥¿±ÃæÀä¡×¤ÈÄêµÁ¤µ¤ì¤ë¡£
¡ÎÉÑÅÙ¡Ï¡¡¼«Á³Î®»º¤ÎȯÀ¸ÉÑÅÙ¤ÏÌó15¡ó¤È¤µ¤ì¡¢¤½¤Î¿¤¯¤¬Ç¥¿±12½µÌ¤Ëþ¤ËȯÀ¸¤¹¤ë¡£ ÊìÂΤβÃÎð¤Ëȼ¤¤ÉÑÅÙ¤¬¹â¤¯¤Ê¤ê¡¢40ºÐ°Ê¾å¤Ç¤ÎÇ¥¿±¤Ç¤ÏÌó25¡ó¤ËÀ¸¤¸¤ë¤È¤µ¤ì¤ë¡£
ȯ¾É»þ´ü¤Ë¤è¤ëʬÎà
­¡Áá´üή»º¡ÊÇ¥¿±12½µÌ¤Ëþ¡Ë ¼«Á³Î®»º¤Î90%°Ê¾å¤òÀê¤á¤ë¡£¸¶°ø¤Î50060¡ó¤ÏÀ÷¿§Âΰ۾ï¤Ç¤¢¤ë¡£
­¢¸å´üή»º¡ÊÇ¥¿±12½µ°Ê¸å0Ç¥¿±22½µÌ¤Ëþ¡Ë å°ÌÓËìÍÓËì±ê¡¢»ÒµÜ´ñ·Á¡¢»ÒµÜ¶Ú¼ð¡¢ »ÒµÜðô´É̵ÎϾɤʤɤÎÊìÂΦ¤Î°Û¾ï¤Ë¤è¤Ã¤ÆÀ¸¤¸¤ë¤³¤È¤¬Â¿¤¤¡£»à»º¤È¤·¤Æ°·¤ï¤ì¤ë¡£
Î×¾²Ê¬Îà
­¡ÀÚÇ÷ή»º¡Êthreatened abortion¡Ë
¡ÎÄêµÁ¡Ï¾¯Î̤νзì¤ä²¼Ê¢ÉôÄˤòȼ¤¦Î®»º¤Ø¤Î°Ü¹Ô¾õÂ֤Ǥ¢¤ë¤¬¡¢ðô´É¤¬Ì¤³«Âç¤Ç¡¢Ä¶²»Çȸ¡ºº¤ÇÂÛ²ê¡ÊÂÛ»ù¡Ë¡¢ ÂÛ»ù¿´Ç郎ǧ¤á¤é¤ì¡¢Àµ¾ïÇ¥¿±¤Ø¤Î²óÉü¤¬²Äǽ¤Ê¾õÂ֤Ǥ¢¤ë¡£å°ÌÓËì²¼·ì¼ð¤¬Ç§¤á¤é¤ì¤ë¤³¤È¤â¤¢¤ë¡£
[¼£ÎÅ¡Ï(1) °ÂÀÅ¡¢²é¾²¡£(2) Ç¥¿±16½µ°Ê¸å¤Ç»ÒµÜ¼ý½Ì¤òǧ¤á¤ë¾ì¹ç¡¢»ÒµÜ¼ý½ÌÍÞÀ©ºÞ¡Ê±ö»À¥ê¥È¥É¥ê¥ó¡Ë¤òÅêÍ¿¤¹¤ë¡£
­¢¿Ê¹Ôή»º¡Êinevitable abortion¡Ë
¡ÎÄêµÁ¡Ïή»º¤¬³«»Ï¤·¡¢¿ØÄËÍͲ¼Ê¢ÄË¡¢½Ð·ì¤¬¶¯¤¯¡¢»ÒµÜðô´É¤¬³«Â礷¤Æ¡¢ÊÝ¸Ū¼£ÎŤÎÂоݤˤʤé¤Ê¤¤¾õÂÖ¡£
¡Î¼£ÎÅ¡ÏÇ¥¿±·Ñ³¤ÏÉÔ²Äǽ¤Ç¤¢¤ë¤¿¤á¡¢»ÒµÜÆâÍÆ½üµî½Ñ¡ÊD&C¡Ë¤ò¹Ô¤¦¡£´°Á´Î®»º¤Ç¤¢¤ì¤Ð¼£ÎŤÏÉÔÍפǤ¢¤ë¡£
­£´°Á´Î®»º¡Êcomplete abortion¡Ë
¡ÎÄêµÁ¡ÏÂ۲ꤢ¤ë¤¤¤ÏÂÛ»ù¤È¤½¤ÎÉÕ°ʪ¤¬´°Á´¤Ë»ÒµÜ³°¤ËÇӽФµ¤ì¤¿¾õÂÖ¡£Ä¶²»Çȸ¡ºº¤ÇÂÛǹ¤Î¾Ã¼º¤òǧ¤á¤ë¡£
¡Î¼£Îšϼ«Á³¤Ë»ÒµÜ¼ý½Ì¤¬µ¯¤³¤êÉü¸Å¤¬¿Ê¤à¤Î¤Ç¼£ÎŤÏÉÔÍפǤ¢¤ë¡£
­¤ÉÔÁ´Î®»º¡Êincomplete abortion¡Ë
¡ÎÄêµÁ¡ÏÂ۲ꤢ¤ë¤¤¤ÏÂÛ»ù¤ÈÉÕ°ʪ¤¬´°Á´¤ËÇӽФµ¤ì¤º¡¢°ìÉô¤¬»ÒµÜÆâ¤Ë»Ä¸¤·¤Æ¤¤¤ë¾õÂÖ¡£½Ð·ì¡¢²¼Ê¢ÉôÄˤ¬»ý³¤¹¤ë¡£
¡Î¼£ÎÅ¡Ï»ÒµÜÆâÍÆ½üµî½Ñ¡£»ÒµÜÆâÍÆÊª¤¬¼«Á³¤ËÇӽФµ¤ì¤ë¤Î¤òÂÔ¤ÄÂÔµ¡ÎÅË¡¤¬¹Ô¤ï¤ì¤ë¾ì¹ç¤â¤¢¤ë¡£
­¥·Îαή»º¡Êmissed abortion¡Ë
¡ÎÄêµÁ¡ÏÇ¥¿±22½µÌ¤Ëþ¤ËÂ۲ꤢ¤ë¤¤¤ÏÂÛ»ù¤¬»àË´¸å¡¢¾É¾õ¤¬¤Ê¤¯»ÒµÜÆâ¤ËÄäÂÚ¤·¤Æ¤¤¤ë¾õÂÖ¡£ ·Îαή»º¤Î¤¦¤Á¡¢ÂÛǹ¤¬25mm°Ê¾å¤ËÂ礭¤¯¤Ê¤Ã¤Æ¤â¡¢ÂÛ»ù¿´Çï¤òǧ¤á¤º¡¢ 1½µ´Ö¸å¤ÎͲ»Çȸ¡ºº¤Ç¤âÂÛǹ¤Îȯ°é¤òǧ¤á¤Ê¤¤¤â¤Î¤ò¸Ï»àÍñ¡Êblighted ovum¡Ë¤È¤¤¤¦¡£
¡Î¼£ÎÅ¡Ï»ÒµÜÆâÍÆ½üµî½Ñ¡£
­¦²½³ØÎ®»º¡Êchemical abortion¡Ë
¡ÎÄêµÁ¡ÏÇ¢Ãæ£èCG¬Äê¤Ê¤É¤ÇÇ¥¿±¤È¿ÇÃǤµ¤ì¤Ê¤¬¤é¤â¡¢Ä¶²»Çȸ¡ºº¤Ë¤ÆÂÛǹ¤¬³Îǧ¤µ¤ì¤ë»þ´ü¤è¤êÁ°¤Ëή»º¡Ê·î·ÐÍͽзì¡Ë ¤Ë¤Ê¤Ã¤Æ¤·¤Þ¤¦¤â¤Î¡£¶áǯ¡¢»ÔÈΤÎÇ¥¿±¸¡ººÌô¤Î´¶ÅÙ¤¬Èó¾ï¤Ë¹â¤¯¤Ê¤ê¡¢½¾Íè¤Ï¡Öή»º¡×¤È¤·¤Æ°Õ¼±¤µ¤ì¤Ê¤«¤Ã¤¿¤â¤Î¤Þ¤Ç ¡Öή»º¡×¤È¤·¤ÆÇ§¼±¤µ¤ì¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¡£²½³ØÎ®»º¤Ï¡¢ÆÃ¤ËÇ¥¿±¤òµ¤¤Ë¤·¤Æ¤¤¤ëÉÔÇ¥´µ¼Ô¤¬µ¤ÉÕ¤¯¤³¤È¤¬Â¿¤¤¡£
­§´¶À÷ή»º¡Êinfectious abortion¡Ë
¡ÎÄêµÁ¡Ïή»º·Ð²áÃæ¤Ë»ÒµÜÆâ´¶À÷¤¬À¸¤¸¤¿¾õÂÖ¡£¤³¤Î¾õÂÖ¤òÊüÃÖ¤¹¤ì¤Ð¡¢ÇÔ·ì¾É¡¢DIC¤Ê¤É¤Î½ÅÆÆ¤Ê¹çÊ»¾É¤ò°ú¤­µ¯¤³¤¹¤¿¤á¡¢ÁáµÞ¤Ë¼£ÎŤ¬É¬ÍפȤʤ롣
¡Î¼£ÎšϹ³¶ÝºÞÅêÍ¿¡¢»ÒµÜÆâÍÆ½üµî½Ñ¡£
¡ý»àÂÛ»ù¾É¸õ·² dead fetus syndrome¡§
·Îαή»º¤äÁÐÂÛ°ì»ù»àË´¤Ê¤É¤Î¾ì¹ç¡¢»àË´»ù¤«¤éʬÈ礵¤ì¤ëÁÈ¿¥°ø»Ò¤¬ÊìÂÎÆâ¤ËήÆþ¡¢·ì±Õ¶Å¸Ç¤¬Ð¶¿Ê¤·¡¢¤½¤Î·ë²Ì¡¢ ÊìÂΤËDIC¤ò°ú¤­µ¯¤³¤¹¤³¤È¤¬¤¢¤ë¡£¤³¤ì¤ò»àÂÛ»ù¾É¸õ·²¤È¤¤¤¦¡£

½Ðŵ¡ÄÆüËÜ»ºÉؿͲʰå²ñ¸¦½¤¥Î¡¼¥È

ÂÛ»ù¿´Çï

Am J Obstet Gynecol. 2007 Jul;197(1):26.e1-6. A framework for standardized management of intrapartum fetal heart rate patterns. ¥¬¥¤¥É¥é¥¤¥ó¤Î¸µ¤Ë¤Ê¤Ã¤¿ÏÀʸ
ÂÛ»ù¿´Çï¿ô¿Þ¤Ë¤ª¤±¤ëÍѸì¤ÈÄêµÁ¡ÊÆüËÜ»º²ÊÉØ¿Í²Ê³Ø²ñ¡¤2003ǯ¡Ë

­µ¡¥ÂÛ»ù¿´Çï¿ô¿Þ¤Î´ðËÜ»ö¹à
(1) °Ê²¼¤ÎÄêµÁ¤ÏÂÛ»ù¿´Çï¿ô¿Þ¤òÆù´ãŪ¤Ë¸«¤ÆÈ½ÃǤµ¤ì¤ë¤â¤Î¤Ç¤¢¤ë¤¬¡¤¾­Íè¤Î¥³¥ó¥Ô¥å¡¼¥¿¤Ë¤è¤ë¼«Æ°¿ÇÃǤˤâŬ±þ¤µ¤ì¤ë¤â¤Î¤È¤¹¤ë¡¥
(2) µ­Ï¿Íѻ桤¥â¥Ë¥¿¡¼¥Ç¥£¥¹¥×¥ì¥¤²èÌ̾å¤Ë¤ª¤¤¤Æ¤â²£¼´¤Îµ­Ï¿Â®Å٤ϣ±Ê¬´Ö¤Ë£³cm¡¤½Ä¼´¤Ïµ­Ï¿»æ£±cm ¤¢¤¿¤ê¿´Çï¿ô¤Ï30bpm ¤òɸ½à¤È¤¹¤ë¡¥
(3) ÂÛ»ù¿´Åſޤ«¤é¤ÎľÀÜͶƳ¤Ë¤è¤ë¿´Çï¿ô·×¬¤¢¤ë¤¤¤ÏͲ»ÇȥɥץéË¡¤Ë¤è¤ë¼«¸ÊÁê´Ø¿´Çï¿ô·×¬¤Î¤É¤Á¤é¤Ë¤âŬ±þ¤µ¤ì¤ë¡¥
(4) °Ê²¼¤ÎÄêµÁ¤Ï¼ç¤ËʬÊÚ»þ¤ÎÂÛ»ù¿´Çï¿ô¿Þ¤ËÂФ¹¤ë¤â¤Î¤Ç¤¢¤ë¤¬¡¤Ç¥¿±Ãæ¤Ë¤ª¤¤¤Æ¤â¤½¤ÎÆÉ¤ßÊý¤ÏƱ¤¸¤È¤¹¤ë¡¥
(5) ÇÈ·Á¤Ï¿´Çï¿ô´ðÀþ¡¤ºÙÊÑÆ°¤ÎÄøÅÙ¡¤¿´Çï¿ô°ì²áÀ­ÊÑÆ°¤ò¤½¤ì¤¾¤ìÊ̸ĤËȽÃǤ¹¤ë¤â¤Î¤È¤¹¤ë¡¥
(6) »ÒµÜ¼ý½Ì¤Ëȼ¤¦ÊѲ½¤Ï¼þ´üÀ­ÊÑÆ°¡Êperiodic change¡Ë¡¤È¼¤ï¤Ê¤¤ÊѲ½¤Ï¶öȯŪÊÑÆ°¡Êepisodic change¡Ë¤È¤¹¤ë¡¥
(7) Ç¥¿±½µ¿ô¡¤»ÒµÜ¼ý½Ì¤Î¾õÂÖ¡¤ÊìÂΡ¤ÂÛ»ù¤Î¾õÂÖ¡¤ÌôʪÅêÍ¿¤Ê¤É¡¤ÂÛ»ù¿´Çï¿ô¤Ë±Æ¶Á¤òÍ¿¤¨¤ë¤È¹Í¤¨¤é¤ì¤ë»ö¹à¤òµ­ºÜ¤¹¤ë¡¥
­¶¡¥ÂÛ»ù¿´Çï¿ô¤ÎÍѸì
A¡¥ÂÛ»ù¿´Çï¿ô´ðÀþ FHR baseline
1¡ËÀµ¾ï¡ÊÀ°¡ËÌ® normocardia¡§110 ¡Á 160bpm
2¡Ë½ùÌ® bradycardia¡§¡ã110bpm ¹âÅÙ½ùÌ®¡§<80bpm
3¡ËÉÑÌ® tachycardia¡§¡ä160bpm
B¡¥ÂÛ»ù¿´Çï¿ô´ðÀþºÙÊÑÆ° FHR baseline variability
C¡¥ÂÛ»ù¿´Çï¿ôÊÑÆ° FHR variability
D¡¥ÂÛ»ù¿´Çï¿ô°ì²áÀ­ÊÑÆ° periodic or episodic change of FHR
1¡Ë°ì²áÀ­ÉÑÌ® acceleration
2¡Ë°ì²áÀ­½ùÌ® deceleration
üñ¡ËÁáȯ°ì²áÀ­½ùÌ® early deceleration
üò¡ËÃÙȯ°ì²áÀ­½ùÌ® late deceleration
üó¡ËÊÑÆ°°ì²áÀ­½ùÌ® variable deceleration
üô¡ËÁ«±ä°ì²áÀ­½ùÌ® prolonged deceleration
­·¡¥ÂÛ»ù¿´Çï¿ô¿ÞÇÈ·Á¤ÎÄêµÁ
A¡¥ÂÛ»ù¿´Çï¿ô´ðÀþ FHR baseline
ÂÛ»ù¿´Çï¿ô´ðÀþ¤Ï10 ʬ¤Î¶è²è¤Ë¤ª¤±¤ë¤ª¤ª¤è¤½¤ÎÊ¿¶ÑÂÛ»ù¿´Çï¿ô¤Ç¤¢¤ê¡¤£µ¤ÎÇÜ¿ô¤È¤·¤ÆÉ½¤¹¡¥ Ãí¡§152bpm¡¤139bpm ¤È¤¤¤¦É½¸½¤ÏÍѤ¤¤º¡¤150bpm¡¤140bpm ¤È£µbpm ¤´¤È¤ÎÁý¸º¤Çɽ¤¹¡¥
ȽÄê¤Ë¤Ï
£±¡¥°ì²áÀ­ÊÑÆ°¤ÎÉôʬ
£²¡¥26bpm °Ê¾å¤ÎÂÛ»ù¿´Çï¿ôºÙÊÑÆ°¤ÎÉôʬ¤ò½ü³°¤¹¤ë¡¥¤Þ¤¿
£³¡¥10 ʬ´Ö¤ËÊ£¿ô¤Î´ðÀþ¤¬¤¢¤ê¡¤¤½¤Î´ðÀþ¤¬26bpm °Ê¾å¤Îº¹¤ò¤â¤Ä¾ì¹ç¤Ï¡¤¤³¤ÎÉôʬ¤Ç¤Î´ðÀþ¤ÏȽÄꤷ¤Ê¤¤¡¥
10 ʬ¤Î¶è²èÆâ¤Ç¡¤´ðÀþ¤ÈÆÉ¤à¾ì½ê¤Ï¾¯¤Ê¤¯¤È¤â£²Ê¬°Ê¾å³¤«¤Ê¤±¤ì¤Ð¤Ê¤é¤Ê¤¤¡¥ ¤½¤¦¤Ç¤Ê¤±¤ì¤Ð¤½¤Î¶è²è¤Î´ðÀþ¤ÏÉÔ³ÎÄê¤È¤¹¤ë¡¥¤³¤Î¾ì¹ç¤Ï¡¤Ä¾Á°¤Î10 ʬ´Ö¤Î¿´Çï¿ô¿Þ¤«¤éȽÄꤹ¤ë¡¥ ¤â¤·ÂÛ»ù¿´Çï¿ô´ðÀþ¤¬110bpm ̤Ëþ¤Ç¤¢¤ì¤Ð½ùÌ®¡Êbradycardia¡Ë¤È¸Æ¤Ó¡¤160bpm ¤ò±Û¤¨¤ë¾ì¹ç¤ÏÉÑÌ®¡Êtachycardia¡Ë¤È¤¹¤ë¡¥
B¡¥ÂÛ»ù¿´Çï¿ô´ðÀþºÙÊÑÆ° FHR baseline variability
ÂÛ»ù¿´Çï¿ô´ðÀþºÙÊÑÆ°¤Ï£±Ê¬´Ö¤Ë£²¥µ¥¤¥¯¥ë°Ê¾å¤ÎÂÛ»ù¿´Çï¿ô¤ÎÊÑÆ°¤Ç¤¢¤ê¡¤¿¶Éý¡¤¼þÇÈ¿ô¤È¤âµ¬Â§À­¤¬¤Ê¤¤¤â¤Î¤ò¤¤¤¦¡¥ sinusoidal pattern ¤Ï¤³¤ÎºÙÊÑÆ°¤ÎʬÎà¤Ë¤ÏÆþ¤ì¤Ê¤¤¡¥ºÙÊÑÆ°¤ò¿¶Éý¤ÎÂ礭¤µ¤Ë¤è¤Ã¤Æ£´Ãʳ¬¤ËʬÎह¤ë¡¥
£±¡¥ºÙÊÑÆ°¾Ã¼º¡Êundetectable¡Ë¡§Æù´ãŪ¤Ëǧ¤á¤é¤ì¤Ê¤¤¡¥
£²¡¥ºÙÊÑÆ°¸º¾¯¡Êminimal¡Ë¡§£µbpm °Ê²¼
£³¡¥ºÙÊÑÆ°ÃæÅùÅÙ¡Êmoderate¡Ë¡§6 ¡Á 25bpm
£´¡¥ºÙÊÑÆ°Áý²Ã¡Êmarked¡Ë¡§26bpm °Ê¾å
¤³¤ÎʬÎà¤ÏÆù´ãŪ¤ËȽÆÉ¤¹¤ë¡¥short term variability, long term variability ¤Îɽ¸½¤Ï¤·¤Ê¤¤¡¥
¡ÊÃí¡Ë¥µ¥¤¥Ê¥½¥¤¥À¥ë¥Ñ¥¿¡¼¥ó sinusoidal pattern ¡¡¥µ¥¤¥Ê¥½¥¤¥À¥ë¥Ñ¥¿¡¼¥ó sinusoidal pattern ¤Ï¿´Çï¿ô¶ÊÀþ¤¬µ¬Â§Åª¤Ç¤Ê¤á¤é¤«¤Ê¥µ¥¤¥ó¶ÊÀþ¤ò¼¨¤¹¤â¤Î¤ò¤¤¤¦¡¥»ý³»þ´Ö¤ÏÌä¤ï¤º¡¤ £±Ê¬´Ö¤Ë£²¡Á£¶¥µ¥¤¥¯¥ë¤Ç¿¶Éý¤ÏÊ¿¶Ñ£µ¡Á 15bpm ¤Ç¤¢¤ê¡¤Â礭¤¯¤Æ¤â35bpm °Ê²¼¤ÎÇÈ·Á¤ò¾Î¤¹¤ë¡¥

C¡¥ÂÛ»ù¿´Çï¿ôºÙÊÑÆ° FHR variability
ÂÛ»ù¿´Çï¿ô´ðÀþ°Ê³°¤ÎÉôʬ¤Ë¤ª¤¤¤Æ¡¤ºÙÊÑÆ°¤òȽÄꤹ¤ëɬÍפ¬¤¢¤ë¾ì¹ç¤â¡¤¾åµ­¤Î£´Ãʳ¬¤ÎʬÎà¤ÏŬ±þ¤µ¤ì¤ë¤â¤Î¤È¤¹¤ë¡¥
D¡¥ÂÛ»ù¿´Çï¿ô°ì²áÀ­ÊÑÆ° periodic or episodic change of FHR
1¡Ë°ì²áÀ­ÉÑÌ® acceleration
°ì²áÀ­ÉÑÌ®¤È¤Ï¿´Çï¿ô¤¬³«»Ï¤«¤é¥Ô¡¼¥¯¤Þ¤Ç¤¬30 ÉÃ̤Ëþ¤ÎµÞ®¤ÊÁý²Ã¤Ç³«»Ï¤«¤éĺÅÀ¤Þ¤Ç¤¬15bpm °Ê¾å¡¤ ¸µ¤ËÌá¤ë¤Þ¤Ç¤Î»ý³¤¬15 Éðʾ売ʬ´Ö̤Ëþ¤Î¤â¤Î¤ò¤¤¤¦¡¥32 ½µÌ¤Ëþ¤Ç¤Ï¿´Çï¿ôÁý²Ã¤¬10bpm °Ê¾å¡¤»ý³¤¬10 Éðʾå¤Î¤â¤Î¤È¤¹¤ë¡¥ Á«±ä°ì²áÀ­ÉÑÌ® prolonged acceleration ÉÑÌ®¤Î»ý³¤¬£² ʬ°Ê¾å¡¤10 ʬ̤Ëþ¤Ç¤¢¤ë¤â¤Î¤ÏÁ«±ä°ì²áÀ­ÉÑÌ®¡Êprolonged acceleration¡Ë¤È¤¹¤ë¡¥10 ʬ°Ê¾å»ý³¤¹¤ë¤â¤Î¤Ï´ðÀþ¤¬ÊѲ½¤·¤¿¤â¤Î¤È¤ß¤Ê¤¹¡¥
2¡Ë°ì²áÀ­½ùÌ® deceleration
üñ¡ËÁáȯ°ì²áÀ­½ùÌ® early deceleration
Ááȯ°ì²áÀ­½ùÌ®¤È¤Ï¡¤»ÒµÜ¼ý½Ì¤Ëȼ¤Ã¤Æ¡¤¿´Çï¿ô¸º¾¯¤Î³«»Ï¤«¤éºÇ²¼ÅÀ¤Þ¤Ç30 Éðʾå¤Î·Ð²á¤Ç´Ë¤ä¤«¤Ë²¼¹ß¤·¡¤ ¤½¤Î¸å»ÒµÜ¼ý½Ì¤Î¾ÃÂà¤Ëȼ¤¤¸µ¤ËÌá¤ë¿´Çï¿ôÄã²¼¤Ç¡¤¤½¤Î°ì²áÀ­½ùÌ®¤ÎºÇ²¼ÅÀ¤ÈÂбþ¤¹¤ë»ÒµÜ¼ý½Ì¤ÎºÇ¶¯ÅÀ¤Î»þ´ü¤¬°ìÃפ·¤Æ¤¤¤ë¤â¤Î¤ò¤¤¤¦¡¥ ¤½¤Î¿´Çï¿ô¸º¾¯¤Ï¡¤Ä¾Á°¤Î¿´Çï¿ô¤è¤ê»»½Ð¤µ¤ì¤ë¡¥
üò¡ËÃÙȯ°ì²áÀ­½ùÌ® late deceleration
ÃÙȯ°ì²áÀ­½ùÌ®¤È¤Ï¡¤»ÒµÜ¼ý½Ì¤Ëȼ¤Ã¤Æ¡¤¿´Çï¿ô¸º¾¯¤Î³«»Ï¤«¤éºÇ²¼ÅÀ¤Þ¤Ç30 Éðʾå¤Î·Ð²á¤Ç´Ë¤ä¤«¤Ë²¼¹ß¤·¡¤ ¤½¤Î¸å»ÒµÜ¼ý½Ì¤Î¾ÃÂà¤Ëȼ¤¤¸µ¤ËÌá¤ë¿´Çï¿ôÄã²¼¤Ç¡¤»ÒµÜ¼ý½Ì¤ÎºÇ¶¯ÅÀ¤ËÃÙ¤ì¤Æ¤½¤Î°ì²áÀ­½ùÌ®¤ÎºÇ²¼ÅÀ¤ò¼¨¤¹¤â¤Î¤ò¤¤¤¦¡¥ ¤½¤Î¿´Çï¿ô¸º¾¯¤Ï¡¤Ä¾Á°¤Î¿´Çï¿ô¤è¤ê»»½Ð¤µ¤ì¤ë¡¥
Ãí¡Ë¤Û¤È¤ó¤É¤Î¾ÉÎã¤Ç¤Ï¡¤°ì²áÀ­½ùÌ®¤Î²¼¹ß³«»Ï¡¦ºÇ²¼ÅÀ¡¦²óÉü¤¬¡¤¤ª¤Î¤ª¤Î»ÒµÜ¼ý½Ì¤Î³«»Ï¡¦ºÇ¶¯ÅÀ¡¦½ªÎ»¤è¤êÃÙ¤ì¤Æ½Ð¸½¤¹¤ë¡¥
üó¡ËÊÑÆ°°ì²áÀ­½ùÌ® variable deceleration
ÊÑÆ°°ì²áÀ­½ùÌ®¤È¤Ï¡¤15bpm °Ê¾å¤Î¿´Çï¿ô¸º¾¯¤¬30 ÉÃ̤Ëþ¤Î·Ð²á¤ÇµÞ®¤Ëµ¯¤³¤ê¡¤¤½¤Î³«»Ï¤«¤é¸µ¤ËÌá¤ë¤Þ¤Ç15 Éðʾ売ʬ̤Ëþ¤òÍפ¹¤ë¤â¤Î¤ò¤¤¤¦¡¥ »ÒµÜ¼ý½Ì¤Ëȼ¤Ã¤Æ½Ð¸½¤¹¤ë¾ì¹ç¤Ï¡¤¤½¤Îȯ¸½¤Ï°ìÄê¤Î·Á¤ò¤È¤é¤º¡¤²¼¹ßÅÙ¡¤»ý³»þ´Ö¤Ï»ÒµÜ¼ý½Ì¤´¤È¤ËÊÑÆ°¤¹¤ë¡¥
Ãí¡Ë»ÒµÜ¼ý½Ì¤¬ÉÔÌÀ¤Î¾ì¹ç¤Ï¡¤Ááȯ°ì²áÀ­½ùÌ®¡¤ÃÙȯ°ì²áÀ­½ùÌ®¡¤ÊÑÆ°°ì²áÀ­½ùÌ®¤Î¶èÊ̤ϤĤ±¤Ê¤¤¡¥
üô¡ËÁ«±ä°ì²áÀ­½ùÌ® prolonged deceleration
Á«±ä°ì²áÀ­½ùÌ®¤È¤Ï¿´Çï¿ô¤Î¸º¾¯¤¬15bpm °Ê¾å¤Ç¡¤³«»Ï¤«¤é¸µ¤ËÌá¤ë¤Þ¤Ç¤Î»þ´Ö¤¬£²Ê¬°Ê¾å10 ʬ̤Ëþ¤Î½ùÌ®¤ò¤¤¤¦¡¥ 10 ʬ°Ê¾å¤Î°ì²áÀ­½ùÌ®¤Î»ý³¤Ï´ðÀþ¤ÎÊѲ½¤È¤ß¤Ê¤¹¡¥

¡ÊÆüËÜ»º²ÊÉØ¿Í²Ê³Ø²ñ ¼þ»º´ü°Ñ°÷²ñ ÂÛ»ù¿´Çï¿ô¿Þ¤ÎÍѸìµÚ¤ÓÄêµÁ¸¡Æ¤¾®°Ñ°÷²ñ¡¥°Ñ°÷Ĺ¡§²¬Â¼½£Çî¡¥2003 ǯÊó¹ð¤è¤ê°ìÉôÈ´¿è¡Ë 30Éäò¶­³¦¤ËÁáȯ°ì²áÀ­½ùÌ®¤¢¤ë¤¤¤ÏÃÙȯ°ì²áÀ­½ùÌ®¤ÈÊÑÆ°°ì²áÀ­½ùÌ®¤ò¶èÊ̤¹¤ë¡£¤³¤ì¤ò30Éå롼¥ë¤È¤¤¤¤¤Þ¤¹¡£ ÊÑÆ°°ì²áÀ­½ùÌ®¤Î½Å¾ÉÅÙʬÎà(Kubli¤ÎʬÎà) ¤Ï°Ê²¼¤ÎÄ̤ê¤Ç¤¹¡£

Á«±ä°ì²áÀ­½ùÌ®¤Î½Å¾ÉÅÙʬÎà¤Ï°Ê²¼¤ÎÄ̤ê¤Ç¤¹¡£

ÃÙȯ°ì²áÀ­½ùÌ®¤Î·ÚÅÙ¡¦¹âÅÙ¤ÎȽÃǤϰʲ¼¤ÎÄ̤ê¤Ç¤¹¡£

°Ê¾å¤Î½ê¸«¤È½Å¾ÉÅÙʬÎफ¤é£µÃʳ¬¤Ë·Ù²üÅÙ¤ò·è¤á¤ÆÄ벦ÀÚ³«Åù¤ÎÂбþ¤È½èÃÖ¤ò·è¤á¤Æ¤¤¤¯ÊýË¡¤¬Äê¤á¤é¤ì¤Þ¤·¤¿¡£ ⤷¡¢ÂÛ»ùµ¡Ç½ÉÔÁ´¤Î¿ÇÃÇÆÃ°ÛÅÙ¤ÏÄ㤯¡¢CTG¤ÇÌäÂê¤ÊÇÈ·Á¤Ç¤â¼ÂºÝ¤ËÂÛ»ù¤ËÌäÂ꤬µ¯¤­¤Æ¤¤¤ë¤³¤È¤ÏÈæ³ÓŪ¾¯¤Ê¤¤¤È¤¤¤ï¤ì¤Æ¤¤¤Þ¤¹¡£ µÕ¤Ë¡¢CTG¤Ç¸µµ¤¤ÊÇÈ·Á¤Î»þ¤Ï¤Þ¤º´Ö°ã¤¤¤Ê¤¯¸µµ¤¤ÈȽÃǤǤ­¤Þ¤¹¡£

Á°·Ç¤ÎÊÆ¹ñ¤ÎÏÀʸ¤«¤é¤Ï¤¤¤¯¤é¤«Êѹ¹¤µ¤ì¤Æ¤¤¤Þ¤¹¡£

ÂÛ»ù·Ù²ü¥ì¥Ù¥ë

1¡¡Àµ¾ïÇÈ·Á
·Ð²á´Ñ»¡
2¡¡°¡Àµ¾ïÇÈ·Á
»º²ÊŪ»ÒµÜÆâ´Ä¶­²þÁ±¡ÊCT¡Ë¡ÊÂΰÌÊÑ´¹¡¦»ÀÁÇ¡¦Í¢±Õ¡¦¥ª¥­¥·¥È¥­¥·¥óÄ´ÀᡦÍÓ¿åÃíÆþ¡¦¼ý½ÌÍÞÀ©Ìô¡Ë
3¡¡°Û¾ïÇÈ·Á¡Ê·ÚÅÙ¡Ë
»º²ÊŪ»ÒµÜÆâ´Ä¶­²þÁ±¡Ü¸¶°øµæÌÀ¡¦´Æ»ë¶¯²½
4¡¡°Û¾ïÇÈ·Á¡ÊÃæÅùÅÙ¡Ë
»º²ÊŪ»ÒµÜÆâ´Ä¶­²þÁ±¡Ü¶ÛµÞÄ벦ÀÚ³«¡¦îé»Ò¡¦µÛ°ú¤Î½àÈ÷
5¡¡°Û¾ïÇÈ·Á¡Ê¹âÅÙ¡Ë
¶ÛµÞÄ벦ÀÚ³«¡¦îé»Ò¡¦µÛ°ú¤Ë¤è¤ëµÞ®¿ëÊÚ

´ðÀþºÙÊÑÆ°Àµ¾ï

¤Ê¤· Ááȯ ·ÚÅÙÊÑÆ° ½ÅÅÙÊÑÆ° ·ÚÅÙÃÙȯ ½ÅÅÙÃÙȯ ·ÚÅÙÁ«±ä ½ÅÅÙÁ«±ä
Àµ¾ïÌ® 1 2 2 3 3 3 3 4
ÉÑÌ® 2 2 3 3 3 4 3 4
·ÚÅÙ½ùÌ® 3 3 3 4 4 4 4 4
¹âÅÙ½ùÌ®¡Ê<80¡Ë 4 4 # 4 4 4 # #

´ðÀþºÙÊÑÆ°¸º¾¯

¤Ê¤· Ááȯ ·ÚÅÙÊÑÆ° ½ÅÅÙÊÑÆ° ·ÚÅÙÃÙȯ ½ÅÅÙÃÙȯ ·ÚÅÙÁ«±ä ½ÅÅÙÁ«±ä
Àµ¾ïÌ® 2 3 3 4 3 4 4 5
ÉÑÌ® 3 3 4 4 4 5 4 5
·ÚÅÙ½ùÌ® 4 4 4 5 5 5 5 5
¹âÅÙ½ùÌ®¡Ê<80¡Ë 5 5 # 5 5 5 # #

´ðÀþºÙÊÑÆ°Áý²Ã

¤Ê¤· Ááȯ ·ÚÅÙÊÑÆ° ½ÅÅÙÊÑÆ° ·ÚÅÙÃÙȯ ½ÅÅÙÃÙȯ ·ÚÅÙÁ«±ä ½ÅÅÙÁ«±ä
Ì®¤Ë´Ø¤ï¤é¤º 2 2 3 3 3 4 3 4

´ðÀþºÙÊÑÆ°¾Ã¼º

¤Ê¤· Ááȯ ·ÚÅÙÊÑÆ° ½ÅÅÙÊÑÆ° ·ÚÅÙÃÙȯ ½ÅÅÙÃÙȯ ·ÚÅÙÁ«±ä ½ÅÅÙÁ«±ä
Ì®¤Ë´Ø¤ï¤é¤º 4 5 5 5 5 5 5 5

¥µ¥¤¥Ê¥½¥¤¥À¥ë¥Ñ¥¿¡¼¥ó

¤Ê¤· Ááȯ ·ÚÅÙÊÑÆ° ½ÅÅÙÊÑÆ° ·ÚÅÙÃÙȯ ½ÅÅÙÃÙȯ ·ÚÅÙÁ«±ä ½ÅÅÙÁ«±ä
Ì®¤Ë´Ø¤ï¤é¤º 4 4 4 4 5 5 5 5

ÀÚÇ÷ÁỺÌô

ÍÑË¡¡¦ÍÑÎÌ ÊìÂΤؤÎÉûºîÍÑ »ù¤Ø¤ÎÉûºîÍÑ ¶Ø´÷
¦ÂºîưÌô ±ö»À¥ê¥È¥É¥ê¥ó¡ö¡¡¡Ê¥¦¥Æ¥á¥ê¥óÃí¡Ë ¡¦ÂоݤÏ16½µ°Ê¹ß¤ÎÀÚÇ÷ήÁỺ
¡¦1 A¡Ê5ml¡Ë¤ò 5% ¥Ö¥É¥¦Åü±Õ¤Þ¤¿¤Ï 10%¥Þ¥ë¥È¡¼¥¹±Õ500ml¤È¤·¡¤50¦Ì g/ ʬ¡Ê30ml/hr¡Ë¤«¤éÅÀÅ©ÀÅÃí
¡¦»ÒµÜ¼ý½ÌÍÞÀ©¡¤ÊìÂο´Çï¿ô¤Ê¤É¤ò´Ñ»¡¤·Áý¸º
¡¦Ä̾ͭ¸úÍÑÎ̤ÏËèʬ50¡Á 150¦Ì g
¡¦ÃíÆþÌôÎ̤ÏËèʬ200¦Ìg¤òͤ¨¤Ê¤¤¤è¤¦¤Ë¤¹¤ë
¡¦Æ°Ø©¡¤ÉÑÌ®¡¤¼ê»Ø¿¶À´éÌÌĬ¹È
¡¦ÓÒµ¤¡¦ÅüÂå¼Õ°Û¾ï
¡¦Ä㥫¥ê¥¦¥à·ì¾É
¡¦ÇÙ¿å¼ð¡¦¿´ÉÔÁ´
¡¦¶»¿å ¡¦ÉÔÀ°Ì®
¡¦Çò·ìµå¸º¾¯¡¦Ìµðùγµå¾É¡¦·ì¾®Èĸº¾¯
¡¦´Îµ¡Ç½¾ã³²¡¦²«áÕ
¡¦ÈéÉæÇ´Ëì´ã¾É¸õ·²¡ÊStevens-Johnson syndrome¡Ë
¡¦²£Ìæ¶ÚÍ»²ò¾É
¿·À¸»ùÉÑÇï¡ÊÉÑÌ®¡Ë¡¤Äã·ìÅü¾É¡¤Ä㥫¥ë¥·¥¦¥à·ì¾É¡¤¹â¥Ó¥ê¥ë¥Ó¥ó·ì¾É¡¤Äã·ì°µ¾É¡¤Ç¾Æâ½Ð·ì¡¤Ä²Êĺɡ¤¿´¼¼Ãæ³ÖÊɤÎÈî¸ü ¡¦Ç¥¿±·Ñ³¤¬´í¸±¤ÈȽÃǤµ¤ì¤ë¾õÂÖ ¡ÊÁáÇí¤Ê¤É¡Ë
¡¦½ÅÆÆ¤Ê¹Ã¾õÁ£µ¡Ç½Ð¶¿Ê¾É¡¤ÅüǢɡ¤¹â·ì°µ¤Ê¤É
¡¦¶Ú¶¯Ä¾À­¥¸¥¹¥È¥í¥Õ¥£¤Ê¤É¤Î¶Ú¼À´µ¤ª¤è¤Ó¤½¤Î´û±ý¤Ï¿µ½ÅÅêÍ¿
β»À¥Þ¥°¥Í¥·¥¦¥à ¡Ê¥Þ¥°¥»¥ó¥È¡Ë ¡¦ÂоݤÏ22½µ°Ê¹ß¤Î¥ê¥È¥É¥ê¥ó̵¸ú¡¤¤Þ¤¿¤Ï»ÈÍѤ¬¤Ç¤­¤Ê¤¤ÀÚÇ÷ÁỺ
¡¦½é²óÎÌ40ml¡ÊMgSO4 4g¡Ë¤ò 20ʬ°Ê¾å¤«¤±¤ÆÅÀÅ©ÅêÍ¿¸å¡¤Ëè»þ10ml¡Ê1g¡Ë¤è¤ê»ý³ÅÀÅ©ÅêÍ¿ ¡¦»ÒµÜ¼ý½Ì¤¬ÍÞÀ©¤µ¤ì¤Ê¤¤¾ì¹ç¤Ï¡¤Ëè»þ5ml ¡Ê0.5g¡Ë¤º¤ÄÁýÎ̤·¡¤ºÇÂçÅêÍ¿Î̤ÏËè»þ20ml¡Ê2g¡Ë¤Þ¤ÇÁýÎ̲ġ¤¼ý½ÌÍÞÀ©¸å¤ÏÁ²¼¡¸ºÎÌ
¡¦»ý³ÃíÆþ¥Ý¥ó¥×¤òÍѤ¤¤ÆÅêÍ¿¤¹¤ë
¡¦Ç®´¶¡¤¸ý³é¡¤Ä¬¹È¡¤·ñÂÕ´¶¡¦ÌµÎϾɡ¦MgÃæÆÇ ¡Ê¹âMg·ì¾É¤Ë¤è¤ê¼æµ¯¡Ë
´ãâÛ²¼¿â¡¤É¨³¸ç§È¿¼Í¾Ã¼º¡¤¶Ú¶ÛÄ¥Äã²¼¡¤¿´µ¡Ç½ÍÞÀ©¡ÊÅÁƳ¾ã³²¡Ë¡¤¸ÆµÛËãáã¡Ê¸ÆµÛ¿ôÄã²¼¡¤¸ÆµÛº¤Æñ¡Ë¡¤·ì°µÄã²¼¤Ê¤É
¡¦²£Ìæ¶ÚÍ»²ò¾É¡§CK¾å¾º¡¤·ìÃæ¡¦Ç¢Ãæ¥ß¥ª¥°¥í¥Ó¥ó¾å¾º
¡¦ÇÙ¿å¼ð¡¤¥¤¥ì¥¦¥¹¤Ê¤É
¿·À¸»ù¶Ú¶ÛÄ¥Äã²¼¡¤Äã·ì°µ¾É¡¤¸ÆµÛ¿ôÄã²¼¡¤MgÃæÆÇ ¡¦½Å¾É¶Ú̵ÎϾÉ
¡¦¿´¥Ö¥í¥Ã¥¯¤Î´û±ý´µ¼Ô
¡¦ÄãÄ´À­Ã¦¿å¾É´µ¼Ô
¡¦¿Õµ¡Ç½¾ã³²¡¤¹âMg·ì¾É¡¤ÄãCa·ì¾É´µ¼Ô¡¤¥ê¥È¥É¥ê¥óÅêÍ¿¼Ô¤Ï¿µ½ÅÅêÍ¿
Ca¥Á¥ã¥ó¥Í¥ë¥Ö¥í¥Ã¥«¡¼ ¥Ë¥Õ¥§¥¸¥Ô¥ó¡Ê¥¢¥À¥é¡¼¥È¡Ë ½é²óÎ̤Ȥ·¤Æ10¡Á 20mg¤òÅêÍ¿¤·¤¿¸å¡¤4¡Á 6»þ´Ö¤´¤È¤Ë10¡Á 20mg¤òÅêÍ¿¤¹¤ë
1ÆüºÇÂç120mg¤ò¸ÂÅ٤Ȥ¹¤ë
Ĭ¹È¡¤Æ¬ÄË¡¤¤á¤Þ¤¤¡¤°­¿´¡¤°ì²áÀ­Äã·ì°µ ¸½ºß¤Î¤È¤³¤í¡¤Ãíµ­¤Ê¤·
PG¹çÀ®Á˳²ºÞ ¥¤¥ó¥É¥á¥µ¥·¥ó ºÁÌô¤â¤·¤¯¤Ï·Ð¸ý¤ÇÇ¥¿±32½µÌ¤Ëþ¤Î¾ÉÎã¤ËÍѤ¤¤ë.½é²óÎ̤Ï100mg(ºÁÌô),¤â¤·¤¯¤Ï50mg(·Ð¸ý)¤Ç³«»Ï¤·, °ú¤­¤Ä¤Å¤­6»þ´Ö¤´¤È¤Ë25mg¤ò·ÐľIJ¼øÍ¿¤·,¥È¡¼¥¿¥ë¤Î»ÈÍÑ´ü´Ö¤Ï48»þ´Ö°Ê²¼,»ÈÍÑÎ̹ç·×200mg°Ê²¼¤¬Ë¾¤Þ¤·¤¤. ·ìÃæÇ»ÅÙ¤Ï,·Ð¸ýÅêÍ¿¤Ç¤Ï1-2»þ´Ö¤Ç¥Ô¡¼¥¯¤Ë㤷,ºÁÌô¤Ç¤Ï¤½¤ì¤è¤ê¤ä¤äÁ᤯¤Ê¤ë °­¿´¡¤¶»¤ä¤± »ù¤Ø¤ÎÉûºîÍѤÏÂç¡§ÍÓ¿å²á¾¯¡¤ÂÛ»ù¿ÕÉÔÁ´¡¤Ä²Àü¹¦¡¤Æ°Ì®´É¼ý½Ì¡ÊÊĺ¿¡Ë¡¤¿·À¸»ùư̮´É³«Â¸¡¤ ÇÙ¹â·ì°µ¾É¡¤Ç¾Æâ½Ð·ì¡¤¹â¥Ó¥ê¥ë¥Ó¥ó·ì¾É¡¤²õ»àÀ­Ä²±ê¤Ê¤É ½ÅÆÆ¤Ê´Î¾ã³²¡¦¿Õ¾ã³²¤Î¤¢¤ë´µ¼Ô

¥Þ¥°¥»¥ó¥È¡Êβ»À¥Þ¥°¥Í¥·¥¦¥à¡Ë

źÉÕʸ½ñ¤Ê¤É¤«¤éÈ´¿è¡£
ËܺÞÅêÍ¿¤Ë¤è¤ê¹â¥Þ¥°¥Í¥·¥¦¥à·ì¾É¤¬µ¯¤³¤ê¡¢¥Þ¥°¥Í¥·¥¦¥àÃæÆÇ¡Ê·ì°µÄã²¼¡¢Ãæ¿õ¿À·ÐÍÞÀ©¡¢¿´µ¡Ç½ÍÞÀ©¡¢¸ÆµÛËã¤ÒÅù¡Ë¤¬¼æµ¯¤µ¤ì¤ë¤³¤È¤¬¤¢¤ë¤¿¤á¡¢ ÅêÍ¿Ãæ¡¢ÆÃ¤ËÅêÍ¿Î̤òÁý²Ã¤µ¤»¤¿¾ì¹ç¤Ë¤Ï¡¢¿µ½Å¤Ê´Ñ»¡¡Êɨ³¸ç§È¿¼Í¤Î³Îǧ¡¢¸ÆµÛ¿ô¤ÎÊÑÆ°¤Î³Îǧ¤¢¤ë¤¤¤Ï·ìÃæ¥Þ¥°¥Í¥·¥¦¥àÇ»Å٤άÄêÅù¡Ë¤ò¹Ô¤¦¤³¤È¡£
·ìÃæ¥Þ¥°¥Í¥·¥¦¥àÇ»Å٤ξ徺¤Ë¤è¤ê¡¢¥Þ¥°¥Í¥·¥¦¥àÃæÆÇ¤ò°ú¤­µ¯¤³¤¹¤³¤È¤¬¤¢¤ë¤Î¤Ç¡¢ ´ãâÛ²¼¿â¡¢É¨³¸ç§È¿¼Í¤Î¾Ã¼º¡¢¶Ú¶ÛÄ¥Äã²¼¡¢¿´Åſް۾ï¡Ê˼¼¼¥Ö¥í¥Ã¥¯¡¢ÅÁƳ¾ã³²¡Ë¡¢¸ÆµÛ¿ôÄã²¼¡¢ ¸ÆµÛº¤ÆñÅù¤¬Ç§¤á¤é¤ì¤¿¾ì¹ç¤Ë¤ÏÅêÍ¿¤òÃæ»ß¤¹¤ëÅù¤ÎŬÀڤʽèÃÖ¤ò¹Ô¤¦¤³¤È¡£¤Ê¤ª¡¢¿´ÇÙÄä»ß¡¢¸ÆµÛÄä»ß¤Ë»ê¤ë¾ì¹ç¤¬¤¢¤ë¡£
²áÎÌÅêÍ¿¤Î¾ì¹ç¤Ë¡¢ÊìÂεڤӿ·À¸»ù¤Ë¹â¥Þ¥°¥Í¥·¥¦¥à·ì¾É¤ò°ú¤­µ¯¤³¤·¡¢Ç®´¶¡¢Ä¬¹È¡¢¸ý³é¡¢·ì°µÄã²¼¡¢Ãæ¿õ¿À·ÐÍÞÀ©¡¢¿´µ¡Ç½ÍÞÀ©¡¢ ¸ÆµÛËãáã¡¢¹ü³Ê¶ÚÃдËÅù¤Î¾É¾õ¤¬¤¢¤é¤ï¤ì¤ë¤³¤È¤¬¤¢¤ë¡£¤Ê¤ª¡¢¼£ÎŤˤϥ«¥ë¥·¥¦¥àºÞ¡Ê¥°¥ë¥³¥ó»À¥«¥ë¥·¥¦¥à¡Ë¤¬Í­¸ú¤Ç¤¢¤ë¤È¤ÎÊó¹ð¤¬¤¢¤ë¡£ ·ìÀ¶¥Þ¥°¥Í¥·¥¦¥àÇ»ÅÙ¤ÈÃæÆÇ¾É¾õ¤Ë¤Ï²¼µ­¤ÎÁê´Ø¤¬ÃΤé¤ì¤Æ¤¤¤ë¡£

Ç»ÅÙ¡Êmg/dL¡Ë 4¡Á7.5 6.7 8.4¡Á12 12¡Á14.4 14.4°Ê¾å
¾É¾õ ¼£ÎŰè Ëö¾¿¶ÚÎÏÄã²¼ ɨ³¸ç§È¿¼Í¾Ã¼º ¸ÆµÛÍÞÀ© ¸ÆµÛËãáã¡¢¸ÆµÛÄä»ß¡¢ÉÔÀ°Ì®¡Ê˼¼¼¥Ö¥í¥Ã¥¯¡¢ÅÁƳ¾ã³²¡Ë

Mg ÃæÆÇ¤òÍ褷¤¿¾ì¹ç¤ÎÂкö¤Ï¡¤Ãæ¿õ¿À·Ð·Ï¤ÎÍÞÀ©¤ä¹ü³Ê¶ÚÃдˤβþÁ±¤ò¿Þ¤ë¤¿¤á¤Ë¡¤MgSO4¤ÎÃæ»ß¤Ë²Ã¤¨¤Æ¡¤ 8.5¡ó¥°¥ë¥³¥ó»ÀCa¡Ê¥«¥ë¥Á¥³¡¼¥ëÃí¼Í±Õ¡Ë10ml ¤ò3 ʬ°Ê¾å¤«¤±¤Æ¤æ¤Ã¤¯¤êiv ¤¹¤ë¤³¤È¤¬½ÅÍפǤ¢¤ë¡¥

¥¨¥³¡¼

ɸ½à²½ÂÛ»ùÂνſäÄê¼°¡ÊÆüËÜͲ»ÇÈ°å³Ø²ñ¡Ë EFW=1.07 x BPD^3 + 0.30 x AC^2 x FL
BPD¤Î¬ÄêÊýË¡
¡¦Â¬ÄêÃÇÌÌ¡§ÂÛ»ùƬÉô¤ÎÀµÃæÀþ¥¨¥³¡¼¤¬Ãæ±û¤ËÉÁ½Ð¤µ¤ì¡¢Æ©ÌÀÃæ³Ö¹Ð¤È»ÍµÖÂÎÁ夬ÉÁ½Ð¤µ¤ì¤ëÃÇÌÌ
¡¦Â¬ÄêÊýË¡¡§Ãµ¿¨»Ò¤Ë¶á¤¤Æ¬³¸¹ü³°Â¦¤«¤éÂЦ¤ÎƬ³¸¹üÆâ¦¤Þ¤Ç¤Îµ÷Î¥¤ò·×¬.
¡¦Æ¬³¸»Ø¿ô(BPD/FOD)¤¬<0.78¤ÇĹƬ¾É¡¢0.88<¤ÇûƬ¾Éµ¿¤¤¡£
AC¤Î¬ÄêÊýË¡
¡¦Â¬ÄêÃÇÌÌ¡§ÂÛ»ù¤ÎÊ¢ÉôÂçÆ°Ì®¤Ëľ¸ò¤¹¤ëÃÇÌ̤ǡ¢ÂÛ»ù¤ÎÊ¢Êɤ«¤éÀÔÄǤޤǤε÷Î¥¤ÎÁ°Êý1/3¤«¤é1/4¤ÎÉô°Ì¤Ë´ÎÆâçÁÀÅÌ®¤ª¤è¤Ó°ßË¢¤¬ÉÁ½Ð¤µ¤ì¤ëÃÇÌÌ
¡¦Â¬ÄêÊýË¡¡§¥¨¥ê¥×¥¹Ë¡¤Ë¤è¤ë¾åµ­ÃÇÌ̤γ°¼þ¤òAC¤È¤¹¤ë
FL¤Î¬ÄêÊýË¡
¡¦Â¬ÄêÃÇÌÌ¡§ÂçÂܹü¤ÎĹ¼´¤¬ºÇ¤âŤ¯¡¢Î¾Ã¼¤Î¹üüÉô¤Þ¤ÇÉÁ½Ð¤µ¤ì¤ëÃÇÌÌ
¡¦Â¬ÄêÊýË¡¡§ÂçÂܹü²½¹üÉôʬξü¤Î¥¨¥³¡¼¤ÎÃæ±û¤«¤éÃæ±û¤ò·×¬¤¹¤ë¡£Æð¹üÉôʬ¤Ï·×¬¤·¤Ê¤¤¡£

Biophysical profile scoring¡ÊBPS¡Ë

¹àÌÜ Àµ¾ï¡Ê¥¹¥³¥¢¡á2ÅÀ¡Ë °Û¾ï¡Ê¥¹¥³¥¢¡á0ÅÀ¡Ë
¸ÆµÛÍͱ¿Æ°
Fetal breathing movements¡ÊFBM¡Ë
30ʬ´Ö¤Î´Ñ»¡²¼¤Ç30Éðʾ峤¯FBM¤ò1²ó°Ê¾åǧ¤á¤ë¡¥ 30ʬ´Ö¤Î´Ñ»¡²¼¤Ç30Éðʾ峤¯FBM¤òǧ¤á¤Ê¤¤¡¥
Â礭¤¤ÂÛÆ°
Gross body movements
30ʬ´Ö¤Ë3²ó°Ê¾å¤Î¶í´´/»Í»è¤Î±¿Æ°¤òǧ¤á¤ë¡Ê¤¿¤À¤·Ï¢Â³¤¹¤ë¤â¤Î¤Ï1²ó¤È¤ß¤Ê¤¹¡Ë¡¥ 30ʬ´Ö¤Î´Ñ»¡²¼¤Ç¶í´´/»Í»è¤ÎÁÆÂ籿ư¤¬2²ó°Ê²¼¡¥
ÂÛ»ù¶Ú¶ÛÄ¥
Fetal tone
¾¯¤Ê¤¯¤È¤â1²ó¤Ï¶í´´¤¢¤ë¤¤¤Ï»Í»è¤¬¶þ°Ì¤«¤é¿­Å¸¤·¡¤¤¹¤°¤ËºÆ¤Ó¶þ°Ì¤Ë¤Ê¤ë±¿Æ°¤¬Ç§¤á¤é¤ì¤ë¤«¡¤¼ê¾¸¤Î³«Êı¿Æ°¤¬¾¯¤Ê¤¯¤È¤â1²ó¤¢¤ë¡¥ »Í»è¤ÏÃæÅùÅٰʾ忭¶þ°Ì¤Ç¡¤¶þ°Ì¤Ë²óÉü¤·¤Ê¤¤¡¥ÂÛÆ°¾Ã¼º¡¥¼ê¾¸¤¬°ìÉô³«¤¤¤¿¤Þ¤Þ¡¥
¥Î¥ó¡¦¥¹¥È¥ì¥¹¥Æ¥¹¥È
Reactive fetal rate
20ʬ´Ö¤ËÂÛÆ°¤Ëȼ¤¦°ì²áÀ­ÉÑÌ®¡Ê15bpm°Ê¾å¡¤15Éðʾå¡Ë¤¬2²ó°Ê¾å¤¢¤ë¡¥ 20ʬ´Ö¤Ç°ì²áÀ­ÉÑÌ®¤¬2²ó̤Ëþ¤â¤·¤¯¤Ï ¡ã15bpm»þ¡¥
ÍÓ¿åÎÌ
Qualitative amniotic fluid volume
¿âľÃÇÌÌÁü¤Ç2cm°Ê¾å¤ÎÍÓ¿å¥Ý¥±¥Ã¥È¤¬Ç§¤á¤é¤ì¤ë¡¥ ÍÓ¿å¥Ý¥±¥Ã¥È¤¬¤Ê¤¤¤«2cm̤Ëþ¡¥

ÂÛ»ù¿´Çï¿ô¥â¥Ë¥¿¥ê¥ó¥°¤ÎÈóŬÍÑ

26¡Á28½µ¤Ç¤Ï¡¢ÂÛ»ùɾ²Á¤ËÂФ¹¤ë¥³¥ó¥»¥ó¥µ¥¹¤ÏÆÀ¤é¤ì¤Æ¤Ê¤¤¡£ ¤³¤Î»þ´ü¤Î̤½Ï¤ÊÂÛ»ù¤Î¾ì¹ç¤Ë¤Ï¡¢acceleration¤¬Ç§¤á¤é¤ì¤Ê¤¤¤³¤È¤ò¤â¤Ã¤Ænon-reassuring ¤È¤Ïɾ²Á¤Ç¤­¤Ê¤¤¡£

»²¹Í¿Þ½ñ

ÂÛ»ù¿ÇÃÇ¡¦´ÉÍý¤ÎABC¡¡¶â˧Ʋ
»º²Ê»Ö˾¤Î¿Í¤Ë¤Ïɬ·È¤Ç¤¹¡£Ê¢Éô¥¨¥³¡¼¤Ï¤³¤ÎËܤò¸«¤ì¤Ð¤è¤¯Ê¬¤«¤ê¤Þ¤¹¡£
ÂÛ»ù¿´Çï¿ô¥â¥Ë¥¿¥ê¥ó¥°½¸Ãæ¥È¥ì¡¼¥Ë¥ó¥°¡¡ÂÛ»ù¿´Çï¿ô¥â¥Ë¥¿¥ê¥ó¥°¼«¸Ê³Ø½¬ÍѣãÄ-£Ò£Ï£ÍÉÕ

KYRÈÇ 2011-04-29 È´

You have the right to remain silent.
Anything you say will be used against you.

	-- One of Nadav Har'El's Email Signatures.

 <Quetzalcoatl_>  How do I write a computer vision program in C on a
                  microcontroller?
           <dyf>  Quetzalcoatl_: with a text editor?
 <Quetzalcoatl_>  Hmm.. Never thought of that. But which editor? Is
                  Notepad good enough?
         <mauke>  no, you need at least Wordpad
       <rindolf>  mauke: I suggest MS Word or at least OpenOffice.org
       <rindolf>  mauke: but in order to really be able to write well, you
                  need a desktop publishing program like Scribus or Adobe
                  FrameMaker.
               *  rindolf wonders which compiler will accept PDFs as
                  input.
       <waiting>  rindolf: /usr/bin/pdftotext
       <rindolf>  waiting: and pray.
       <rindolf>  There's an estoric programming language called Piet (I
                  think) that accepts images as input.

    -- How to write stylistic code
    -- ##programming, Freenode


Powered by UNIX fortune(6)
[ Main Page ]